Drug Survival Associated with Effectiveness and Safety of Treatment with Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients with Psoriasis

Zenas Z.N. Yiu*, Gabrielle Becher, Brian Kirby, Philip Laws, Nick J. Reynolds, Catherine H. Smith, Richard B. Warren, Christopher E.M. Griffiths

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

72 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Drug Survival Associated with Effectiveness and Safety of Treatment with Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients with Psoriasis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science